Article Details
Retrieved on: 2021-03-26 23:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
OncoQuest Pharmaceuticals' technology platform includes a portfolio of tumor antigen specific monoclonal antibodies targeting CA-125, MUC1, PSA ...
Article found on: www.newswire.ca
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here